Cargando…

Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance

BACKGROUND: Regulatory T lymphocytes (Treg) are characterized by the presence of CD4+ surface antigen. Today the transcription factor FOXP3 is considered to be the most specific marker of Treg cells. The aim of the study was to estimate the percentage of T(reg) in peripheral blood and the tissue of...

Descripción completa

Detalles Bibliográficos
Autores principales: Winkler, Izabela, Wilczynska, Barbara, Bojarska-Junak, Agnieszka, Gogacz, Marek, Adamiak, Aneta, Postawski, Krzysztof, Darmochwal-Kolarz, Dorota, Rechberger, Tomasz, Tabarkiewicz, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513978/
https://www.ncbi.nlm.nih.gov/pubmed/26077607
http://dx.doi.org/10.1186/s13048-015-0164-0
_version_ 1782382730317660160
author Winkler, Izabela
Wilczynska, Barbara
Bojarska-Junak, Agnieszka
Gogacz, Marek
Adamiak, Aneta
Postawski, Krzysztof
Darmochwal-Kolarz, Dorota
Rechberger, Tomasz
Tabarkiewicz, Jacek
author_facet Winkler, Izabela
Wilczynska, Barbara
Bojarska-Junak, Agnieszka
Gogacz, Marek
Adamiak, Aneta
Postawski, Krzysztof
Darmochwal-Kolarz, Dorota
Rechberger, Tomasz
Tabarkiewicz, Jacek
author_sort Winkler, Izabela
collection PubMed
description BACKGROUND: Regulatory T lymphocytes (Treg) are characterized by the presence of CD4+ surface antigen. Today the transcription factor FOXP3 is considered to be the most specific marker of Treg cells. The aim of the study was to estimate the percentage of T(reg) in peripheral blood and the tissue of the epithelial ovarian tumor and blood serum TGF-beta concentrations and relationships between them. Moreover, the aim of the study was to answer the question whether the percentage of Treg lymphocytes affects the time of survival in patients with ovarian cancer. METHODS: The patients were divided into four groups, depending on the histopathological examination result: I – a group without any pathology within the ovaries (C; n = 20), II – a group with benign tumors (B; n = 25), III – with borderline tumors (BR; n = 11), IV – a group with cancer of the ovary (M; n = 24). The percentage of Treg lymphocytes in peripheral blood and the tissue was assessed using the flow cytometry method. TGF-beta cytokine concentration was estimated with the ELISA immunoenzymatic test. Statistical analysis of the results was conducted using the computer program Statistica 10.0PL (StatSoft, Inc). RESULTS: No significant differences were found in percentages of Treg lymphocytes in peripheral blood between individual groups of patients (p = 0.11). However, we observed marked differences in the tissue of malignant and non-malignant tumors between individual groups of patients (p = 0.003). The analysis with the post hoc test revealed significantly higher TGF-beta concentration in the group of women with malignant tumors. Moreover, no relationship was found between TGF-beta concentration and the percentage of T(reg) cells in peripheral blood and tumors of the ovary. No correlation was found between the percentage of Treg lymphocytes in peripheral blood (p = 0.4) and the tissue of ovarian tumors (p = 0.3) and the time of survival of patients with ovarian cancer. CONCLUSIONS: The recruitment of Treg lymphocytes toward the tumor is one of the mechanisms of escape of neoplasm from the response of the immune system. The percentage of Treg lymphocytes in peripheral blood and the neoplastic tissue does not influence the time of survival of patients with ovarian cancer.
format Online
Article
Text
id pubmed-4513978
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45139782015-07-25 Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance Winkler, Izabela Wilczynska, Barbara Bojarska-Junak, Agnieszka Gogacz, Marek Adamiak, Aneta Postawski, Krzysztof Darmochwal-Kolarz, Dorota Rechberger, Tomasz Tabarkiewicz, Jacek J Ovarian Res Research BACKGROUND: Regulatory T lymphocytes (Treg) are characterized by the presence of CD4+ surface antigen. Today the transcription factor FOXP3 is considered to be the most specific marker of Treg cells. The aim of the study was to estimate the percentage of T(reg) in peripheral blood and the tissue of the epithelial ovarian tumor and blood serum TGF-beta concentrations and relationships between them. Moreover, the aim of the study was to answer the question whether the percentage of Treg lymphocytes affects the time of survival in patients with ovarian cancer. METHODS: The patients were divided into four groups, depending on the histopathological examination result: I – a group without any pathology within the ovaries (C; n = 20), II – a group with benign tumors (B; n = 25), III – with borderline tumors (BR; n = 11), IV – a group with cancer of the ovary (M; n = 24). The percentage of Treg lymphocytes in peripheral blood and the tissue was assessed using the flow cytometry method. TGF-beta cytokine concentration was estimated with the ELISA immunoenzymatic test. Statistical analysis of the results was conducted using the computer program Statistica 10.0PL (StatSoft, Inc). RESULTS: No significant differences were found in percentages of Treg lymphocytes in peripheral blood between individual groups of patients (p = 0.11). However, we observed marked differences in the tissue of malignant and non-malignant tumors between individual groups of patients (p = 0.003). The analysis with the post hoc test revealed significantly higher TGF-beta concentration in the group of women with malignant tumors. Moreover, no relationship was found between TGF-beta concentration and the percentage of T(reg) cells in peripheral blood and tumors of the ovary. No correlation was found between the percentage of Treg lymphocytes in peripheral blood (p = 0.4) and the tissue of ovarian tumors (p = 0.3) and the time of survival of patients with ovarian cancer. CONCLUSIONS: The recruitment of Treg lymphocytes toward the tumor is one of the mechanisms of escape of neoplasm from the response of the immune system. The percentage of Treg lymphocytes in peripheral blood and the neoplastic tissue does not influence the time of survival of patients with ovarian cancer. BioMed Central 2015-06-17 /pmc/articles/PMC4513978/ /pubmed/26077607 http://dx.doi.org/10.1186/s13048-015-0164-0 Text en © Winkler et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Winkler, Izabela
Wilczynska, Barbara
Bojarska-Junak, Agnieszka
Gogacz, Marek
Adamiak, Aneta
Postawski, Krzysztof
Darmochwal-Kolarz, Dorota
Rechberger, Tomasz
Tabarkiewicz, Jacek
Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance
title Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance
title_full Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance
title_fullStr Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance
title_full_unstemmed Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance
title_short Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance
title_sort regulatory t lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513978/
https://www.ncbi.nlm.nih.gov/pubmed/26077607
http://dx.doi.org/10.1186/s13048-015-0164-0
work_keys_str_mv AT winklerizabela regulatorytlymphocytesandtransforminggrowthfactorbetainepithelialovariantumorsprognosticsignificance
AT wilczynskabarbara regulatorytlymphocytesandtransforminggrowthfactorbetainepithelialovariantumorsprognosticsignificance
AT bojarskajunakagnieszka regulatorytlymphocytesandtransforminggrowthfactorbetainepithelialovariantumorsprognosticsignificance
AT gogaczmarek regulatorytlymphocytesandtransforminggrowthfactorbetainepithelialovariantumorsprognosticsignificance
AT adamiakaneta regulatorytlymphocytesandtransforminggrowthfactorbetainepithelialovariantumorsprognosticsignificance
AT postawskikrzysztof regulatorytlymphocytesandtransforminggrowthfactorbetainepithelialovariantumorsprognosticsignificance
AT darmochwalkolarzdorota regulatorytlymphocytesandtransforminggrowthfactorbetainepithelialovariantumorsprognosticsignificance
AT rechbergertomasz regulatorytlymphocytesandtransforminggrowthfactorbetainepithelialovariantumorsprognosticsignificance
AT tabarkiewiczjacek regulatorytlymphocytesandtransforminggrowthfactorbetainepithelialovariantumorsprognosticsignificance